Wed, November 8, 2023
Tue, November 7, 2023
Mon, November 6, 2023
Sun, November 5, 2023
Fri, November 3, 2023

Jeffrey Zekauskas Maintained (CC) at Hold with Decreased Target to $26 on, Nov 7th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-26-on-nov-7th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jeffrey Zekauskas of JP Morgan, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $38 to $26 on, Nov 7th, 2023.

Jeffrey has made no other calls on CC in the last 4 months.



There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 4 agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Duffy Fischer of "Goldman Sachs" Maintained at Hold with Decreased Target to $30 on, Tuesday, October 31st, 2023
  • Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
  • Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
  • Arun Viswanathan of "RBC Capital" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023


This is the rating of the analyst that currently disagrees with Jeffrey


  • John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $39 on, Monday, October 30th, 2023

Publication Contributing Sources